Identification of Cross Talk between FoxM1 and RASSF1A as a Therapeutic Target of Colon Cancer
Sign Up to like & getrecommendations! Published in 2019 at "Cancers"
DOI: 10.3390/cancers11020199
Abstract: Metastatic colorectal cancer (mCRC) is characterized by the expression of cellular oncogenes, the loss of tumor suppressor gene function. Therefore, identifying integrated signaling between onco-suppressor genes may facilitate the development of effective therapy for mCRC.… read more here.
Keywords: rassf1a; colon cancer; expression; foxm1 rassf1a ... See more keywords